Efficacy of a general practitioner training campaign for early detection of melanoma in France

被引:0
作者
Grange, F. [1 ]
Woronoff, A. S. [3 ]
Bera, R. [1 ]
Colomb, M. [1 ]
Lavole, B. [4 ]
Fournier, E. [3 ]
Arnold, F. [5 ]
Barbe, C. [2 ]
机构
[1] Hop Robert Debre, Serv Dermatol, Reims, France
[2] Hop Robert Debre, Unite Aide Methodol, Reims, France
[3] CHRU Besancon, Registre Tumeurs Doubs & Terr Belfort, Besancon, France
[4] Reseau Cancerol Champagne Ardenne, Reims, France
[5] Assoc Dept Profess Sante Depistage Canc, Reims, France
关键词
CUTANEOUS MALIGNANT-MELANOMA; EDUCATION PROGRAM; IMPROVED SURVIVAL; HEALTH-EDUCATION; EARLY-DIAGNOSIS; MORTALITY; CANCER; EPIDEMIOLOGY; POPULATION; TRENDS;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background To date, no strategy for improving early diagnosis of melanoma has been evaluated on a population basis in France. Objective To evaluate the efficacy of a general practitioner (GP) awareness and training campaign in a pilot French geographical region (Champagne-Ardenne), including 1.34 million inhabitants, 1241 GPs, 56 dermatologists and a population-based melanoma registry. Methods All GPs received repeated awareness postal mailings in 2008 and 398 (32.1%) attended training sessions organized by 27 dermatologists. The pre-(2005-7) and post-campaign (2009-11) periods were compared for the following: primary endpoint - the world-standardized incidence of very thick melanomas (VTM) (Breslow thickness >= 3 mm); secondary endpoints - the mean Breslow thickness; the proportions of VTM and of thin (< 1 mm) melanomas among invasive cases; and the ratio of in situ/all melanoma cases. Similar measures were performed in the control area of Doubs/Belfort territory (655 000 ha), where no similar campaign was carried out. Results The incidence of VTM decreased from 1.07 to 0.71 per 100 000 habitants per year (P = 0.01), the mean Breslow thickness from 1.95 to 1.68 mm (P = 0.06) and the proportion of VTM from 19.2% to 12.8% (P = 0.01). The proportion of thin and in situ melanomas increased from 50.9% to 57.4% (P = 0.05) and from 20.1% to 28.2% (P = 0.001), respectively. No significant variation was observed in Doubs/Belfort territory. Conclusion These results strongly support the efficacy of such a campaign targeting GPs and provide a rationale for a larger public health campaign in France, including training of GPs by dermatologists and encouraging patients to ask their GP for a systematic skin examination.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 40 条
[1]   Clinical and pathological characteristics of melanoma: a population-based study in a French regional population [J].
Barbe, C. ;
Hibon, E. ;
Vitry, F. ;
Le Clainche, A. ;
Grange, F. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (02) :159-164
[2]   Systematic skin cancer screening in Northern Germany [J].
Breitbart, Eckhard W. ;
Waldmann, Annika ;
Nolte, Sandra ;
Capellaro, Marcus ;
Greinert, Ruediger ;
Volkmer, Beate ;
Katalinic, Alexander .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (02) :201-211
[3]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[4]   Melanoma Thickness Trends in the United States, 1988-2006 [J].
Criscione, Vincent D. ;
Weinstock, Martin A. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (03) :793-797
[5]  
CRISTOFOLINI M, 1993, CANCER, V71, P370, DOI 10.1002/1097-0142(19930115)71:2<370::AID-CNCR2820710217>3.0.CO
[6]  
2-M
[7]   EXPERIENCE OF A PUBLIC-EDUCATION PROGRAM ON EARLY DETECTION OF CUTANEOUS MALIGNANT-MELANOMA [J].
DOHERTY, VR ;
MACKIE, RM .
BRITISH MEDICAL JOURNAL, 1988, 297 (6645) :388-391
[8]  
Durbec F, 2010, ARCH DERMATOL, V146, P240, DOI 10.1001/archdermatol.2010.10
[9]   Estimates of cancer incidence and mortality in Europe in 2008 [J].
Ferlay, J. ;
Parkin, D. M. ;
Steliarova-Foucher, E. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) :765-781
[10]   Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma [J].
Flaherty, Keith T. ;
Robert, Caroline ;
Hersey, Peter ;
Nathan, Paul ;
Garbe, Claus ;
Milhem, Mohammed ;
Demidov, Lev V. ;
Hassel, Jessica C. ;
Rutkowski, Piotr ;
Mohr, Peter ;
Dummer, Reinhard ;
Trefzer, Uwe ;
Larkin, James M. G. ;
Utikal, Jochen ;
Dreno, Brigitte ;
Nyakas, Marta ;
Middleton, Mark R. ;
Becker, Juergen C. ;
Casey, Michelle ;
Sherman, Laurie J. ;
Wu, Frank S. ;
Ouellet, Daniele ;
Martin, Anne-Marie ;
Patel, Kiran ;
Schadendorf, Dirk .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02) :107-114